C. Chaparro et al., STATUS OF LUNG-TRANSPLANT RECIPIENTS SURVIVING BEYOND 5 YEARS, The Journal of heart and lung transplantation, 16(5), 1997, pp. 511-516
Citations number
18
Categorie Soggetti
Cardiac & Cardiovascular System",Transplantation,"Respiratory System
Background: Prolonged survival after lung transplantation is now commo
nplace as a result of advances in surgical techniques and postoperativ
e management protocols. Although 1- and 5-year functional and survival
data after lung transplantation are well known, sparse information is
available regarding functional status of recipients surviving beyond
5 years. Methods: The medical records and pulmonary function study res
ults of lung transplant recipients who had survived at least 5 years a
s of September 1995 were retrospectively reviewed. Results: Of the 76
transplantations performed between November 1983 and September 1990, 3
0 (39.5%) were double lung transplantations, and 46 (60.5%) were singl
e lung transplantations. Thirty-one recipients were alive 5 years afte
r transplantation (12 double lung transplantations, 19 single lung tra
nsplantations). The 5-, 6-, and 7-year survival rates were 44%, 34%, a
nd 29%, respectively. There was no association or difference in cytome
galovirus status, sex, and blood group between those who died within 5
years and those who survived beyond 5 years. The median percent predi
cted FEVs for single and double lung transplant recipients were as fol
lows: 5 yrs-75%, 75%; 6 years-73%, 75%; 7 years-68%, 73%. The proporti
on of recipients with bronchiolitis obliterans syndrome according to p
ublished criteria was as follows: stage 0, 32%; stage I, 19%; stage II
, 16%; and stage III, 19%. The functional status (i.e., active, workin
g, disabled) 5 years after transplantation was as follows: active/work
ing, 74%; active but not working, 13%; some limitation/independent, 10
%; and disabled, 3%. Conclusion: Bronchiolitis obliterans syndrome is
a frequent occurrence in long-term survivors. Nevertheless, in spite o
f this condition, most recipients have acceptable lung function, are a
ctive, and are generally working.